Quantcast

Latest Stem cells Stories

2014-06-04 12:29:10

Surveyed U.S. Payers Will Accept High Yearly Costs for Effective Novel Treatments, According to Findings from Decision Resources Group BURLINGTON, Mass., June 4, 2014 /PRNewswire/ -- Decision Resources Group finds that surveyed U.S. retinal specialists are highly willing to prescribe key emerging therapies for the treatment of geographic atrophy (GA), the dry form of advanced age-related macular degeneration (AMD). In particular, clinicians expect to prescribe Roche/Genentech's lampalizumab...

2014-06-03 23:02:06

On June 3, at the 7th Annual Massachusetts Life Sciences Innovation Day, Dr. James L. Sherley, Director of The Adult Stem Cell Technology Center, LLC presented a new technology developed to identify drug candidates that are toxic to adult stem cells. This first technology of its kind meets a long-standing unmet need of the pharmaceutical industry, with potential to save billions of dollars in drug development costs each year while accelerating the arrival of new effective, and safe, drugs...

2014-06-03 12:38:22

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Biobanking for Medicine: Technology, Industry and Market 2014-2024http://www.reportbuyer.com/pharma_healthcare/biotechnology/biobanking_medicine_technology_market.html Report DetailsBiobanks - how to find business trends, R&D, and revenue forecastsWhat does the future hold for medical biobanks? Now you get technological and commercial predictions from 2014. Stay ahead, then, for data,...

2014-06-03 12:37:18

LONDON, June 3, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Translational Regenerative Medicine: Market Prospects 2014-2024http://www.reportbuyer.com/pharma_healthcare/research_r_d/translational_regenerative_medicine_market_prospects_2012_2022.html Report DetailsOur new study shows you the commercial potential of regenerative treatmentsWhat does the future hold for regenerative medicine? Visiongain's brand new report shows you potential revenues to...

2014-06-03 11:48:40

University of Colorado Denver At the 50th Annual Meeting of the American Society for Clinical Oncology (ASCO), University of Colorado Cancer Center researchers reported results of a Phase I trial of OMP-54F28 (FZD8-Fc), an investigational drug candidate discovered by OncoMed Pharmaceuticals targeting cancer stem cells (CSCs). The drug was generally well tolerated, and several of the 26 patients with advanced solid tumors experienced stable disease for greater than six months. Three trials...

2014-06-02 23:09:54

Stem Cell Research Products Market says full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell therapies market to be $3.31 billion, for a total of $6.53 billion. Dallas, Texas (PRWEB) June 02, 2014 According to report “Stem Cell Research Products Market - Opportunities, Tools, and Technologies” as of 2014, several broad categories of stem cells exist, including:     Embryonic stem cells,...

2014-06-02 08:31:56

SACRAMENTO, Calif., June 2, 2014 /PRNewswire/ -- SynGen Inc., a company focused on the development and commercialization of instrument systems that harvest stem and progenitor cells from umbilical cord blood, bone marrow, peripheral blood, and cell culture, announced today that Dr. William Gerber has been appointed CEO to replace co-founder and lead inventor Philip Coelho. Mr. Coelho, who will become the Chief Technical Officer (CTO) of SynGen, noted "Bud Barry, my business partner and...

2014-06-02 08:29:08

On August 1, 2013 The Company issued 75,000,000 million shares as part of a venture to open restaurants in association with South Of The Border Holdings, Inc.; 70 Million have been canceled and returned to the company treasury. SARASOTA, Fla., June ­­2, 2014 /PRNewswire/ -- Caribbean International Holdings (OTC: CIHN) announced today that 70 million of the 75 million shares issued by the Company as part of a venture in association with South Of The Border Holdings, has been...

2014-05-29 20:23:02

COSTA MESA, Calif., May 29, 2014 /PRNewswire/ -- DaVinci Biosciences, LLC announced today that their paper on "Human Prenatal Intestine Cells as a Valuable Source of Stem Cells and Epithelial Cells; Phenotypic and Functional Characterization" has been accepted for publication in the peer-reviewed journal CELL & TISSUE TRANSPLANTATION & THERAPY. With the current move by researchers and governments to reduce the use of animals in drug development and testing, scientists are...

2014-05-29 15:51:33

University of Chicago Medical Center Pinpointing cause of relapse could lead to better therapies A multi-institutional team of researchers has pinpointed exactly what goes wrong when chronic lymphocytic leukemia (CLL) patients develop resistance to ibrutinib, a highly effective, precisely targeted anti-cancer drug. In a correspondence published online May 28 in the New England Journal of Medicine, they show how the mutation triggers resistance. Their finding could guide development of...


Word of the Day
lambent
  • Licking.
  • Hence Running along or over a surface, as if in the act of licking; flowing over or along; lapping or bathing; softly bright; gleaming.
This word comes the Latin 'lambere,' to lick.
Related